News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Subscribe
BIOSIMILAR APPROVALS
Business Practice
Business
Development
Legal
Policy
Practice
Regulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Subscribe
BIOSIMILAR APPROVALS
Advertisement
Business Practice
Business
Development
Legal
Policy
Practice
Regulatory
Tony Hagen
home
/
authors
/
tony-hagen
Tony Hagen is senior managing editor for The Center for Biosimilars®.
Articles
<
1
...
Latest Updated Articles
Published: July 2nd 2025
| Updated: July 9th 2025
Real-World Data Suggest Long-Term Safety of CT-P13 in IBD, RA
Published: October 12th 2020
| Updated: July 9th 2025
Biosimilars Poll: What is Your Opinion on Clinical Efficacy Trials?
Published: June 15th 2025
| Updated: July 9th 2025
Biosimilar Misconceptions, PBM Transparency, and Value-Based Care: Insights From Canavan & O'Dell
Published: June 11th 2025
| Updated: July 9th 2025
European Data Confirm Real-World Benefits of Adalimumab Biosimilars
Published: June 12th 2025
| Updated: July 9th 2025
Biosimilar FYB202 Shows Therapeutic Equivalence to Ustekinumab for Plaque Psoriasis
Published: May 28th 2025
| Updated: July 9th 2025
British Columbia’s Biosimilar Policy Shows No Impact on Hospital Visits